High Doses of Δ9 -Tetrahydrocannabinol Might Impair Irinotecan Chemotherapy: A Review of Potentially Harmful Interactions

Clinical Drug Investigation
Nevenka KopjarAna Lucić Vrdoljak

Abstract

This review proposes the hypothesis that the effectiveness of irinotecan chemotherapy might be impaired by high doses of concomitantly administered Δ9-tetrahydrocannabinol (THC). The most important features shared by irinotecan and THC, which might represent sources of potentially harmful interactions are: first-pass hepatic metabolism mediated by cytochrome P450 (CYP) enzyme CYP3A4; glucuronidation mediated by uridine diphosphate glycosyltransferase (UGT) enzymes, isoforms 1A1 and 1A9; transport of parent compounds and their metabolites via canalicular ATP-binding cassette (ABC) transporters ABCB1 and ABCG2; enterohepatic recirculation of both parent compounds, which leads to an extended duration of their pharmacological effects; possible competition for binding to albumin; butyrylcholinesterase (BChE) inhibition by THC, which might impair the conversion of parent irinotecan into the SN-38 metabolite; mutual effects on mitochondrial dysfunction and induction of oxidative stress; potentiation of hepatotoxicity; potentiation of genotoxicity and cytogenetic effects leading to genome instability; possible neurotoxicity; and effects on bilirubin. The controversies associated with the use of highly concentrated THC preparations with...Continue Reading

References

Dec 24, 1997·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E WassermanE Cvitkovic
Sep 28, 1998·Cancer Chemotherapy and Pharmacology·L Iyer, M J Ratain
Mar 27, 2002·Cancer Chemotherapy and Pharmacology·Lalitha IyerUlrich Mayer
Jan 21, 2003·American Journal of Physiology. Lung Cellular and Molecular Physiology·Theodore A SarafianMichael D Roth
Jun 19, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S De MarcoC N Sternberg
May 10, 2005·DNA Repair·Bennett Van HoutenJanine H Santos
Oct 21, 2005·Pain Research & Management : the Journal of the Canadian Pain Society = Journal De La Société Canadienne Pour Le Traitement De La Douleur·Iain J McGilveray
Nov 8, 2005·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Nicola F SmithAlex Sparreboom
Nov 10, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Nielka P H van ErpHans Gelderblom
Dec 14, 2005·Cancer Letters·Floris A de JongRon H J Mathijssen
Jan 28, 2006·The Journal of Pharmacology and Experimental Therapeutics·Hao-Jie ZhuC Lindsay Devane
Sep 9, 2006·Cancer Treatment Reviews·Charles FuchsPaulo M Hoff
Sep 29, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Christiane Pauli-Magnus, Peter J Meier
Nov 17, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Snezana MirkovFederico Innocenti
Apr 5, 2007·The Oncologist·Frederike K EngelsRon H J Mathijssen
May 23, 2007·Basic & Clinical Pharmacology & Toxicology·Nevenka KopjarAleksandra Fucić
Aug 23, 2007·Chemistry & Biodiversity·Marilyn A Huestis
Sep 18, 2007·Cancer Biology & Therapy·Floris A de JongJaap Verweij
Oct 2, 2007·British Journal of Pharmacology·M L HollandJ C Arnold
Oct 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles S FuchsJosé Barrueco
May 23, 2008·Addiction·Jennifer McLarenSteve Allsop
Jun 19, 2008·Cancer Treatment Reviews·Dinemarie KweekelHans Gelderblom
Jan 13, 2009·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Tripta BansalSushama Talegaonkar
Apr 3, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Anna MazurJeffery H Moran
Aug 12, 2009·Basic & Clinical Pharmacology & Toxicology·Ana Lucić VrdoljakNevenka Kopjar
Oct 27, 2009·Toxicology in Vitro : an International Journal Published in Association with BIBRA·R KontekK Grzegorczyk
Feb 5, 2010·Complementary Therapies in Clinical Practice·Maida J Sewitch, Yamina Rajput
Mar 6, 2010·The AAPS Journal·Vishnudutt PurohitDavid Shurtleff
Mar 10, 2010·Biotechnology Journal·Stephan W BarthMelanie Esselen
Feb 18, 2011·British Journal of Pharmacology·Yosef SarneOra Keren
May 11, 2011·IUBMB Life·Gabriella FanaliMauro Fasano
Jun 1, 2011·Basic & Clinical Pharmacology & Toxicology·Anica Horvat KneževićVesna Benković

❮ Previous
Next ❯

Citations

Mar 17, 2021·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Qingyan RuanGuoyin Kai

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nihon rinsho. Japanese journal of clinical medicine
Akira Yokoyama
Current Clinical Pharmacology
Ken-ichi Fujita, Alex Sparreboom
Journal of Pediatric Hematology/oncology
Peter J Houghton, Victor M Santana
© 2021 Meta ULC. All rights reserved